IRF3 and type 2 diabetes mellitus: Furthermore, IRF3−/− mice develop obesity, insulin resistance, glucose intolerance, and finally, type 2 diabetes due to an increase in proinflammatory macrophages (M1) and the concomitant loss of IL-10 in adipose tissue [79].